Gestational diabetes & diabetes in pregnancy

Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy

Diabetes Technol TherPublished Randomised controlled trial

Authors' conclusion

CGM within group differences were seen for time <63 mg/dL favoring HCL therapy and TIR favoring SAPT (third trimester vs. baseline). Safety and adverse pregnancy outcomes were similar between groups.

Study context

Population
Pregnancies with T1D, enrolled in first trimester, randomised at 14–18 weeks of gestation; therapy until 4–6 weeks postpartum
Participants
11 vs 12
Comparison
Hybrid closed-loop (HCL) vs sensor-augmented pump therapy (SAPT)
  • HCLn = 11
  • SAPTn = 12reference
Methodological detailspilot feasibility, investigator-initiated, two-site, single-blind, HCL group used assistive techniques, e.g. fake carbohydrate boluses and exiting HCL overnight
  • Pilot feasibility
  • Investigator-initiated
  • Two-site
  • Single-blind
  • HCL group used assistive techniques, e.g. fake carbohydrate boluses and exiting HCL overnight

Primary result

As reported in the abstract

Gestational safety: severe hypoglycaemia and DKA after randomisation
  • No severe hypoglycemia (SH) or diabetic ketoacidosis (DKA) episode after randomisation

Further findings

Mean sensor glucose · third trimester · lower with SAPT

P < 0.05

Time <54 mg/dL

Did not differ between groups

Time <63 mg/dL in HCL, within-group change vs run-in · second and third trimester vs run-in

HCL second trimester (SE 1.3%)
3.5%
HCL third trimester (SE 1.3%)
2.8%
HCL run-in (SE 1.3%)
7.9%
Decrease vs run-in, both trimesters
P < 0.05 for both
  • Decreased in both groups, significantly in HCL

Time-in-range (TIR) (63-140 mg/dL) in SAPT, within-group change vs run-in · third trimester vs run-in

SAPT third trimester (SE 3.1%)
68.2%
SAPT run-in (SE 3.1%)
64.3%
Increase vs run-in
P < 0.05

Gestational health outcomes

Did not differ between groups

Safety

SH and DKA · after randomisation

SH or DKA episodes
0

Original publication

Randomized Trial of Assisted Hybrid Closed-Loop Therapy Versus Sensor-Augmented Pump Therapy in Pregnancy. Diabetes Technol Ther. Published 18 March 2024. doi:10.1089/dia.2024.0012

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.